Parkinson's Disease Trial, Recruiting NCT05482126 Sponsor: University of Alabama at Birmingham Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT05482126
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Parkinson's disease (PD):

  • Adults aged 18 or older
  • People who have been diagnosed with confirmed, advanced Parkinson's disease based on established medical guidelines
  • People whose brain MRI scan before surgery was normal or essentially normal
  • People who are able to attend follow-up appointments for the full length of the study
  • People whose treating doctor has already decided that deep brain stimulation (DBS) surgery is part of their routine care, and that a specific brain region called the subthalamic nucleus is the right surgical target

For people joining as healthy comparison participants (controls):

  • Adults aged 18 or older
  • People who have not been diagnosed with Parkinson's disease, any other movement disorder, or any other significant neurological condition

Who may not be able to join:

For people with Parkinson's disease:

  • People under 18 years of age
  • People with certain medical conditions that could increase surgical risk, such as uncontrolled high blood pressure, heart disease, or blood clotting problems
  • People who have been diagnosed with, or are suspected of having, an atypical form of Parkinsonism (such as PSP, MSA, or CBD), medication-caused Parkinsonism, or a significant neurological condition other than Parkinson's disease
  • People who have been diagnosed with a movement disorder that has a psychological rather than neurological cause
  • People who have previously had DBS surgery or a brain tissue ablation procedure
  • People who have been diagnosed with dementia, or whose memory and thinking test scores fall below the 5th percentile for their age and education level (based on standard pre-surgical testing)
  • People who are unable to stop taking Parkinson's medications for at least 12 hours before a scheduled visit

For healthy comparison participants:

  • People under 18 years of age
  • People who have previously been diagnosed with Parkinson's disease, another movement disorder, or any other significant neurological condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zachary Irwin, PhD, The University of Alabama at Birmingham

Phone: (205) 934-6704

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
8 June 2022
Est. completion
1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Kinematic response to stimulus (intraoperative); Kinematic response to stimulus (postoperative); Latency of response to stimulus (intraoperative); Latency of response to stimulus (postoperative); Neural response to stimulus

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov